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The use of small RNAs to program gene regulation and genome defense necessitates ever-
changing choices about the sequences used for small-RNA biogenesis. Dumesic et al. now reveal
stalled spliceosomes as a trigger for small-RNA biogenesis in the pathogenic fungusCryptococcus
neoformans.A striking feature of RNA-based silencing
is its adaptability. In most eukaryotes,
a silencing ‘‘hardware’’ that includes
Argonaute proteins and other silencing
factors stands ready to act, but on its
own, it lacks the information needed to
identify appropriate regulatory or invasive
RNA targets. Various categories of 20–
30 nucleotide (nt) RNAs, including short
interfering RNAs (siRNAs), microRNAs
(miRNAs), and piwi-interacting RNAs
(piRNAs), constitute the ‘‘software’’ that
instructs this silencing machinery about
its targets. By using a system that is
programmable rather than hardwired,
cells can respond to ever-changing
regulatory needs on the fly, simply by
changing the pool of sequences that
feed into the small-RNA biogenesis path-
ways. Once the basic hardware-software
framework was established, natural
selection could identify many different
small-RNA biogenesis criteria that pro-
vide adaptive value, the classic example
being extensively double-stranded char-
acter. In this issue of Cell, Dumesic et al.
(2013) now reveal stalled spliceosomes,
the ribonucleoprotein complexes that
remove introns from pre-messenger
RNAs (pre-mRNAs), as a previously
unappreciated source of small silencing
RNAs in the opportunistic fungal path-
ogen Cryptococcus neoformans.
Previous analyses established the pre-
sence of functional RNA silencing path-
ways in C. neoformans and implicated
orthologs of known silencing factors,
including an RNA-dependent RNA poly-
merase (Rdp1), two Dicers (Dcr1/2), and
an Argonaute (Ago1) (Wang et al., 2010).
This study yielded an interesting twist—
silencing efficacy increases dramatically
during mating and meiosis, a phenom-938 Cell 152, February 28, 2013 ª2013 Elsevenon dubbed ‘‘sex-induced silencing.’’
However, silencing is still apparent
during mitotic growth (Wang et al., 2010,
2012), and Dumesic et al. (2013) began
their examination of C. neoformans
siRNA biogenesis by profiling the small-
RNA population in vegetatively grow-
ing haploid cells. Intriguingly, a majority
of the reads were antisense to trans-
poson or transposon-like centromeric
sequences with apparently suboptimal
introns. Their data set included reads
that spanned intron/exon junctions, sug-
gesting origins related to pre-mRNAs
and, by inference, the nucleus.
To pursue this connection further, Du-
mesic et al. (2013) conducted a series of
coimmunoprecipitation, candidate gene
inactivation, two-hybrid, and fluores-
cence microscopic analyses and identi-
fied a protein complex they have termed
Spliceosome-Coupled And Nuclear RNAi
(SCANR). This complex is composed of
Rdp1, Ago1, and three additional proteins
they have named Qip1, Gwc1, and Srr1.
This last protein provided another unex-
pected link between small RNAs and
introns, given its similar domain structure
to SR proteins, which are well-known
pre-mRNA splicing regulators (Shepard
and Hertel, 2009).
Could these correlative and physical
links reflect functional connections?
Yes—removing introns from an otherwise
robust siRNA-generating locus led to
a dramatic decrease in siRNA production
from that gene. Conversely, when the
authors used splice-site mutations to
compromise the splicing of a non-small-
RNA-generating gene, it became a much
more efficient source of small RNAs.
Tellingly, the latter effect depended on
the nature of the splicing block. 30ier Inc.splice-site mutant pre-mRNAs, which
assemble into spliceosomes but stall
before the second catalytic step, ex-
hibited a strong increase in siRNA
production. By contrast, 50 splice-site
mutations, which bypass the splicing
pathway, did not, suggesting a specific
role for the SCANR complex’s physical
engagement with the spliceosome.
Exploring the mechanism further
(Figure 1), the authors found that deletion
of the gene DBR1, which encodes the
debranching enzyme that linearizes ex-
cised intron lariats or stalled spliceosomal
intermediates destined for degradation,
completely blocked the production of
these siRNAs. Based on these results,
Dumesic et al. (2013) propose that a
kinetic competition between splicing
and siRNA production operates during
mRNA biogenesis. Suboptimally spliced
introns exhibit a greater dwell time on
spliceosomes, and pre-mRNAs in these
stalled spliceosomes are substrates for
the synthesis of siRNAs that will be used
to dampen expression from the same
intron-containing loci.
What could be the functional rationale
for linking stalled spliceosomes to siRNA
production? Dumesic et al. (2013) argue
that this connection gives the RNAi
pathway another entre´e into transposon
silencing, which is a well-established
natural role for small-RNA pathways in
many species (Malone and Hannon,
2009). The molecular logic here is that,
when a foreign genetic element invades
a cell, its introns are unlikely to arrive
preoptimized for that species’ splicing
machinery and that the resulting stalled
spliceosomes constitute an effective
reflection of ‘‘non-self’’ status. The speci-
fic genes examined in this paper include
Figure 1. ASpliceosome-Based Source of Small RNAsPrograms the
Silencing Machinery in C. neoformans
The protein components of the RNA-silencing machinery require small RNAs
derived from double-stranded RNAs and other sources to direct the
complexes to specific targets. In C. neoformans, spliceosomes stall
on suboptimal introns. These arrested complexes engage the SCANR
complex, which uses the bound pre-mRNAs or splicing intermediates (likely
after debranching by the Dbr1 enzyme) as templates for small-RNA bio-
synthesis. This novel pathway and the SCANR complex are highlighted. The
spliceosome-derived small RNAs constitute a new input into the silencing
machinery.some that are annotated
as transposon-like, but the
proposed role for the SCANR
pathway in limiting transposi-
tion as such awaits further
direct tests. Given the selfish
nature of transposons, this
model predicts the existence
of strong selective pressure
toward either intron loss or
intron optimization in trans-
poson-encoded genes in
C. neoformans, but these
predictions are not borne out
in the data of Dumesic et al.
(2013). They suggest two
nonexclusive explanations.
First, some transposons may
have simply invaded too
recently for such pressure to
have acted. Second, they
note that splice sites near
transposon termini can mini-
mize the deleterious effects
of transposons on the loci
that they disrupt. At the
same time, these splice sites
can potentially compromise
expression of transposon se-
quences themselves. Thus,
they argue that weak splice
sites could be specificallyfavored as an adaptive compromise
between these opposing forces.
What of the suboptimally spliced tran-
scripts in the host genome? Suboptimal
introns are a hallmark of regulated
splicing (Nilsen and Graveley, 2010) in
part because their splicing can be readily
modulated both positively and negatively.
How can RNA silencing rely on the
discrimination by the spliceosome
without diminishing the spliceosome’s
regulatory potential on endogenous
targets? Furthermore, could the splicing
of particular transcripts be regulated
under specific circumstances as a means
to induce small-RNA silencing of those
same genes? The discovery of the
SCANR complex provides an exciting
opportunity to answer these questions.RNA-silencing pathways interface
directly with many critical steps of eukary-
otic gene expression and regulation,
including chromatin assembly, transcrip-
tion, mRNA stability, and translation.
With a few tantalizing exceptions (e.g.,
Allo´ et al., 2009; Bayne et al., 2008;
Ruby et al., 2007), pre-mRNA splicing
has been conspicuously absent from this
list. But this appears to be changing,
thanks in part to the work of Dumesic
et al. (2013). Indeed, a very recent and
compelling phylogenetic connection has
been identified between the splicing
machinery and the RNAi apparatus
(Tabach et al., 2013). siRNAs derived
from stalled splicing complexes, as
described by Dumesic et al. (2013), could
represent an elegant exploitation of theCell 152, February 28spliceosome’s highly honed
aptitude for accuracy. Its dis-
criminatory capacity, which
normally supports the fidelity
and regulation of endogenous
gene expression, likely sup-
ports genome integrity as
well. Even beyond this speci-
fic model, the discovery of
the SCANR complex opens
an intriguing door into the
regulatory potential of the
spliceosome and the RNA-
silencing machinery and how
they are intertwined and
coordinated.REFERENCES
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